{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:43:15Z","timestamp":1762623795526,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T00:00:00Z","timestamp":1471910400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/73719\/2010","UID\/DTP\/00776\/2013","SFRH\/BPD\/113014\/2015","PEst-OE\/SAU\/UI0776\/2014"],"award-info":[{"award-number":["SFRH\/BD\/73719\/2010","UID\/DTP\/00776\/2013","SFRH\/BPD\/113014\/2015","PEst-OE\/SAU\/UI0776\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"N\u00facleo Regional do Norte da Liga Portuguesa Contra o Cancro"},{"name":"IPO Porto Research Center","award":["CI-IPOP-16-2012"],"award-info":[{"award-number":["CI-IPOP-16-2012"]}]},{"name":"TVI"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s10549-016-3948-z","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T01:11:45Z","timestamp":1471914705000},"page":"245-256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity"],"prefix":"10.1007","volume":"159","author":[{"given":"Pedro","family":"Pinto","sequence":"first","affiliation":[]},{"given":"Paula","family":"Paulo","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"Manuela","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Peixoto","sequence":"additional","affiliation":[]},{"given":"Manuel R.","family":"Teixeira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,8,23]]},"reference":[{"issue":"5182","key":"3948_CR1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66\u201371","journal-title":"Science"},{"issue":"6559","key":"3948_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789\u2013792. doi: 10.1038\/378789a0","journal-title":"Nature"},{"issue":"11","key":"3948_CR3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Douglas F, Hodgson S, Walker L, Porteous ME, Morrison PJ, Side LE, Kennedy MJ, Houghton C, Donaldson A, Rogers MT, Dorkins H, Miedzybrodzka Z, Gregory H, Eason J, Barwell J, McCann E, Murray A, Antoniou AC, Easton DF, Embrace (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812\u2013822. doi: 10.1093\/jnci\/djt095","journal-title":"J Natl Cancer Inst"},{"key":"3948_CR4","unstructured":"National Comprehensive Cancer Network (2016) Genetic\/Familial High-Risk Assessment: Breast and Ovarian (Version 2.2016). http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf . Accessed May 2016"},{"issue":"8","key":"3948_CR5","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S1470-2045(14)70228-1","volume":"15","author":"J Ledermann","year":"2014","unstructured":"Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott CL, Meier W, Shapira-Frommer R, Safra T, Matei D, Fielding A, Spencer S, Dougherty B, Orr M, Hodgson D, Barrett JC, Matulonis U (2014) Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol 15(8):852\u2013861. doi: 10.1016\/S1470-2045(14)70228-1","journal-title":"Lancet Oncol"},{"issue":"6178","key":"3948_CR6","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1126\/science.1251827","volume":"343","author":"FJ Couch","year":"2014","unstructured":"Couch FJ, Nathanson KL, Offit K (2014) Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science 343(6178):1466\u20131470. doi: 10.1126\/science.1251827","journal-title":"Science"},{"issue":"1","key":"3948_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/cge.12441","volume":"88","author":"A Peixoto","year":"2015","unstructured":"Peixoto A, Santos C, Pinto P, Pinheiro M, Rocha P, Pinto C, Bizarro S, Veiga I, Principe AS, Maia S, Castro F, Couto R, Gouveia A, Teixeira MR (2015) The role of targeted BRCA1\/BRCA2 mutation analysis in hereditary breast\/ovarian cancer families of Portuguese ancestry. Clin Genet 88(1):41\u201348. doi: 10.1111\/cge.12441","journal-title":"Clin Genet"},{"issue":"16","key":"3948_CR8","doi-asserted-by":"publisher","first-page":"8287","DOI":"10.1158\/0008-5472.CAN-05-4247","volume":"66","author":"CC Wu","year":"2006","unstructured":"Wu CC, Shete S, Amos CI, Strong LC (2006) Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome. Cancer Res 66(16):8287\u20138292. doi: 10.1158\/0008-5472.CAN-05-4247","journal-title":"Cancer Res"},{"issue":"6","key":"3948_CR9","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/gast.2001.29611","volume":"121","author":"PD Pharoah","year":"2001","unstructured":"Pharoah PD, Guilford P, Caldas C, International Gastric Cancer Linkage C (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121(6):1348\u20131353","journal-title":"Gastroenterology"},{"issue":"10","key":"3948_CR10","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/1078-0432.CCR-06-0083","volume":"12","author":"N Hearle","year":"2006","unstructured":"Hearle N, Schumacher V, Menko FH, Olschwang S, Boardman LA, Gille JJ, Keller JJ, Westerman AM, Scott RJ, Lim W, Trimbath JD, Giardiello FM, Gruber SB, Offerhaus GJ, de Rooij FW, Wilson JH, Hansmann A, Moslein G, Royer-Pokora B, Vogel T, Phillips RK, Spigelman AD, Houlston RS (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12(10):3209\u20133215. doi: 10.1158\/1078-0432.CCR-06-0083","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3948_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/jmedgenet-2012-101339","volume":"50","author":"V Bubien","year":"2013","unstructured":"Bubien V, Bonnet F, Brouste V, Hoppe S, Barouk-Simonet E, David A, Edery P, Bottani A, Layet V, Caron O, Gilbert-Dussardier B, Delnatte C, Dugast C, Fricker JP, Bonneau D, Sevenet N, Longy M, Caux F, French Cowden Disease N (2013) High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet 50(4):255\u2013263. doi: 10.1136\/jmedgenet-2012-101339","journal-title":"J Med Genet"},{"issue":"6","key":"3948_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F, Tomiak E, Neuhausen SL, Teo ZL, Khan S, Aittomaki K, Moilanen JS, Turnbull C, Seal S, Mannermaa A, Kallioniemi A, Lindeman GJ, Buys SS, Andrulis IL, Radice P, Tondini C, Manoukian S, Toland AE, Miron P, Weitzel JN, Domchek SM, Poppe B, Claes KB, Yannoukakos D, Concannon P, Bernstein JL, James PA, Easton DF, Goldgar DE, Hopper JL, Rahman N, Peterlongo P, Nevanlinna H, King MC, Couch FJ, Southey MC, Winqvist R, Foulkes WD, Tischkowitz M (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497\u2013506. doi: 10.1056\/NEJMoa1400382","journal-title":"N Engl J Med"},{"issue":"28","key":"3948_CR13","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1200\/JCO.2010.34.0778","volume":"29","author":"C Cybulski","year":"2011","unstructured":"Cybulski C, Wokolorczyk D, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Masojc B, Deebniak T, Gorski B, Blecharz P, Narod SA, Lubinski J (2011) Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol 29(28):3747\u20133752. doi: 10.1200\/JCO.2010.34.0778","journal-title":"J Clin Oncol"},{"issue":"4","key":"3948_CR14","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/bcr2919","volume":"13","author":"DE Goldgar","year":"2011","unstructured":"Goldgar DE, Healey S, Dowty JG, Da Silva L, Chen X, Spurdle AB, Terry MB, Daly MJ, Buys SM, Southey MC, Andrulis I, John EM, Bcfr, kConFab, Khanna KK, Hopper JL, Oefner PJ, Lakhani S, Chenevix-Trench G (2011) Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Res 13(4):R73. doi: 10.1186\/bcr2919","journal-title":"Breast Cancer Res"},{"issue":"4","key":"3948_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/ijc.23168","volume":"122","author":"N Bogdanova","year":"2008","unstructured":"Bogdanova N, Feshchenko S, Schurmann P, Waltes R, Wieland B, Hillemanns P, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Varon R, Dork T (2008) Nijmegen Breakage Syndrome mutations and risk of breast cancer. Int J Cancer 122(4):802\u2013806. doi: 10.1002\/ijc.23168","journal-title":"Int J Cancer"},{"issue":"22","key":"3948_CR16","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","volume":"305","author":"V Bonadona","year":"2011","unstructured":"Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, Guimbaud R, Buecher B, Bignon YJ, Caron O, Colas C, Nogues C, Lejeune-Dumoulin S, Olivier-Faivre L, Polycarpe-Osaer F, Nguyen TD, Desseigne F, Saurin JC, Berthet P, Leroux D, Duffour J, Manouvrier S, Frebourg T, Sobol H, Lasset C, Bonaiti-Pellie C, French Cancer Genetics N (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305(22):2304\u20132310. doi: 10.1001\/jama.2011.743","journal-title":"JAMA"},{"issue":"9","key":"3948_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/ng.893","volume":"43","author":"C Loveday","year":"2011","unstructured":"Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Frankum JR, Bowden G, Kalmyrzaev B, Warren-Perry M, Snape K, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L, Breast Cancer Susceptibility C, Eccles D, Evans DG, Renwick A, Seal S, Lord CJ, Ashworth A, Reis-Filho JS, Antoniou AC, Rahman N (2011) Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet 43(9):879\u2013882. doi: 10.1038\/ng.893","journal-title":"Nat Genet"},{"issue":"5","key":"3948_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/ng.2224","volume":"44","author":"C Loveday","year":"2012","unstructured":"Loveday C, Turnbull C, Ruark E, Xicola RM, Ramsay E, Hughes D, Warren-Perry M, Snape K, Breast Cancer Susceptibility C, Eccles D, Evans DG, Gore M, Renwick A, Seal S, Antoniou AC, Rahman N (2012) Germline RAD51C mutations confer susceptibility to ovarian cancer. Nat Genet 44(5):475\u2013476. doi: 10.1038\/ng.2224 (author reply 476)","journal-title":"Nat Genet"},{"key":"3948_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv214","author":"SJ Ramus","year":"2015","unstructured":"Ramus SJ, Song H, Dicks E, Tyrer JP, Rosenthal AN, Intermaggio MP, Fraser L, Gentry-Maharaj A, Hayward J, Philpott S, Anderson C, Edlund CK, Conti D, Harrington P, Barrowdale D, Bowtell DD, Alsop K, Mitchell G, Group AS, Cicek, Cunningham JM, Fridley BL, Alsop J, Jimenez-Linan M, Poblete S, Lele S, Sucheston-Campbell L, Moysich KB, Sieh W, McGuire V, Lester J, Bogdanova N, Durst M, Hillemanns P, OvarianCancerAssociation C, Odunsi K, Whittemore AS, Karlan BY, Dork T, Goode EL, Menon U, Menon U, Jacobs IJ, Antoniou AC, Pharoah PD, Gayther SA (2015) Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer. J Natl Cancer Inst. doi: 10.1093\/jnci\/djv214","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"3948_CR20","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372(23):2243\u20132257. doi: 10.1056\/NEJMsr1501341","journal-title":"N Engl J Med"},{"issue":"8","key":"3948_CR21","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddu733","volume":"24","author":"C Dong","year":"2015","unstructured":"Dong C, Wei P, Jian X, Gibbs R, Boerwinkle E, Wang K, Liu X (2015) Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum Mol Genet 24(8):2125\u20132137. doi: 10.1093\/hmg\/ddu733","journal-title":"Hum Mol Genet"},{"issue":"3","key":"3948_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310\u2013315. doi: 10.1038\/ng.2892","journal-title":"Nat Genet"},{"issue":"8","key":"3948_CR23","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/humu.22101","volume":"33","author":"C Houdayer","year":"2012","unstructured":"Houdayer C, Caux-Moncoutier V, Krieger S, Barrois M, Bonnet F, Bourdon V, Bronner M, Buisson M, Coulet F, Gaildrat P, Lefol C, Leone M, Mazoyer S, Muller D, Remenieras A, Revillion F, Rouleau E, Sokolowska J, Vert JP, Lidereau R, Soubrier F, Sobol H, Sevenet N, Bressac-de Paillerets B, Hardouin A, Tosi M, Sinilnikova OM, Stoppa-Lyonnet D (2012) Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico\/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat 33(8):1228\u20131238. doi: 10.1002\/humu.22101","journal-title":"Hum Mutat"},{"issue":"22","key":"3948_CR24","doi-asserted-by":"publisher","first-page":"13534","DOI":"10.1093\/nar\/gku1206","volume":"42","author":"X Jian","year":"2014","unstructured":"Jian X, Boerwinkle E, Liu X (2014) In silico prediction of splice-altering single nucleotide variants in the human genome. Nucleic Acids Res 42(22):13534\u201313544. doi: 10.1093\/nar\/gku1206","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"3948_CR25","doi-asserted-by":"publisher","first-page":"e3062","DOI":"10.1371\/journal.pone.0003062","volume":"3","author":"R Chrisanthar","year":"2008","unstructured":"Chrisanthar R, Knappskog S, Lokkevik E, Anker G, Ostenstad B, Lundgren S, Berge EO, Risberg T, Mjaaland I, Maehle L, Engebretsen LF, Lillehaug JR, Lonning PE (2008) CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer. PLoS ONE 3(8):e3062. doi: 10.1371\/journal.pone.0003062","journal-title":"PLoS ONE"},{"issue":"12","key":"3948_CR26","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1093\/hmg\/dds101","volume":"21","author":"W Roeb","year":"2012","unstructured":"Roeb W, Higgins J, King MC (2012) Response to DNA damage of CHEK2 missense mutations in familial breast cancer. Hum Mol Genet 21(12):2738\u20132744. doi: 10.1093\/hmg\/dds101","journal-title":"Hum Mol Genet"},{"issue":"18","key":"3948_CR27","doi-asserted-by":"publisher","first-page":"8966","DOI":"10.1158\/0008-5472.CAN-06-1990","volume":"66","author":"N Sodha","year":"2006","unstructured":"Sodha N, Mantoni TS, Tavtigian SV, Eeles R, Garrett MD (2006) Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation. Cancer Res 66(18):8966\u20138970. doi: 10.1158\/0008-5472.CAN-06-1990","journal-title":"Cancer Res"},{"issue":"4","key":"3948_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10689-009-9251-y","volume":"8","author":"C Pinto","year":"2009","unstructured":"Pinto C, Veiga I, Pinheiro M, Peixoto A, Pinto A, Lopes JM, Reis RM, Oliveira C, Baptista M, Roque L, Regateiro F, Cirnes L, Hofstra RM, Seruca R, Castedo S, Teixeira MR (2009) TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset. Fam Cancer 8(4):383\u2013390. doi: 10.1007\/s10689-009-9251-y","journal-title":"Fam Cancer"},{"issue":"1","key":"3948_CR29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.38.1.43","volume":"38","author":"A Chompret","year":"2001","unstructured":"Chompret A, Abel A, Stoppa-Lyonnet D, Brugieres L, Pages S, Feunteun J, Bonaiti-Pellie C (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38(1):43\u201347","journal-title":"J Med Genet"},{"issue":"12","key":"3948_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cancergen.2013.11.005","volume":"206","author":"R Daber","year":"2013","unstructured":"Daber R, Sukhadia S, Morrissette JJ (2013) Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets. Cancer Genet 206(12):441\u2013448. doi: 10.1016\/j.cancergen.2013.11.005","journal-title":"Cancer Genet"},{"issue":"2","key":"3948_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40291-015-0136-5","volume":"19","author":"D Dacheva","year":"2015","unstructured":"Dacheva D, Dodova R, Popov I, Goranova T, Mitkova A, Mitev V, Kaneva R (2015) Validation of an NGS approach for diagnostic BRCA1\/BRCA2 mutation testing. Mol Diagn Ther 19(2):119\u2013130. doi: 10.1007\/s40291-015-0136-5","journal-title":"Mol Diagn Ther"},{"issue":"11","key":"3948_CR32","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","volume":"22","author":"L Castera","year":"2014","unstructured":"Castera L, Krieger S, Rousselin A, Legros A, Baumann JJ, Bruet O, Brault B, Fouillet R, Goardon N, Letac O, Baert-Desurmont S, Tinat J, Bera O, Dugast C, Berthet P, Polycarpe F, Layet V, Hardouin A, Frebourg T, Vaur D (2014) Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet 22(11):1305\u20131313. doi: 10.1038\/ejhg.2014.16","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"3948_CR33","doi-asserted-by":"publisher","first-page":"e97408","DOI":"10.1371\/journal.pone.0097408","volume":"9","author":"HK Chong","year":"2014","unstructured":"Chong HK, Wang T, Lu HM, Seidler S, Lu H, Keiles S, Chao EC, Stuenkel AJ, Li X, Elliott AM (2014) The validation and clinical implementation of BRCAplus: a comprehensive high-risk breast cancer diagnostic assay. PLoS One 9(5):e97408. doi: 10.1371\/journal.pone.0097408","journal-title":"PLoS One"},{"issue":"2","key":"3948_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jmoldx.2014.11.004","volume":"17","author":"D Trujillano","year":"2015","unstructured":"Trujillano D, Weiss ME, Schneider J, Koster J, Papachristos EB, Saviouk V, Zakharkina T, Nahavandi N, Kovacevic L, Rolfs A (2015) Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and\/or ovarian cancer. J Mol Diagn 17(2):162\u2013170. doi: 10.1016\/j.jmoldx.2014.11.004","journal-title":"J Mol Diagn"},{"issue":"10","key":"3948_CR35","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/bioinformatics\/bts146","volume":"28","author":"J Li","year":"2012","unstructured":"Li J, Lupat R, Amarasinghe KC, Thompson ER, Doyle MA, Ryland GL, Tothill RW, Halgamuge SK, Campbell IG, Gorringe KL (2012) CONTRA: copy number analysis for targeted resequencing. Bioinformatics 28(10):1307\u20131313. doi: 10.1093\/bioinformatics\/bts146","journal-title":"Bioinformatics"},{"issue":"19","key":"3948_CR36","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/bioinformatics\/btr462","volume":"27","author":"JF Sathirapongsasuti","year":"2011","unstructured":"Sathirapongsasuti JF, Lee H, Horst BA, Brunner G, Cochran AJ, Binder S, Quackenbush J, Nelson SF (2011) Exome sequencing-based copy-number variation and loss of heterozygosity detection: exomeCNV. Bioinformatics 27(19):2648\u20132654. doi: 10.1093\/bioinformatics\/btr462","journal-title":"Bioinformatics"},{"key":"3948_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2105-10-80","volume":"10","author":"C Xie","year":"2009","unstructured":"Xie C, Tammi MT (2009) CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinformatics 10:80. doi: 10.1186\/1471-2105-10-80","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"3948_CR38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10549-010-1036-3","volume":"127","author":"M Pertesi","year":"2011","unstructured":"Pertesi M, Narod S, Pinheiro M, Pinto P, Soares MJ, Rocha P, Gusmao L, Amorim A, van der Hout A, Gerdes AM, Thomassen M, Kruse TA, Cruger D, Sunde L, Bignon YJ, Uhrhammer N, Cornil L, Rouleau E, Lidereau R, Yannoukakos D, Pertesi M, Narod S, Royer R, Costa MM, Lazaro C, Feliubadalo L, Grana B, Blanco I, de la Hoya M, Caldes T, Maillet P, Benais-Pont G, Pardo B, Laitman Y, Friedman E, Velasco EA, Duran M, Miramar MD, Valle AR, Calvo MT, Vega A, Blanco A, Diez O, Gutierrez-Enriquez S, Balmana J, Ramon T, Cajal y, Alonso C, Baiget M, Foulkes W, Tischkowitz M, Kyle R, Sabbaghian N, Ashton-Prolla P, Ewald IP, Rajkumar T, Mota-Vieira L, Giannini G, Gulino A, Achatz MI, Carraro DM, de Paillerets BB, Remenieras A, Benson C, Casadei S, King MC, Teugels E, Teixeira (2011) International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation. Breast Cancer Res Treat 127(3):671\u2013679. doi: 10.1007\/s10549-010-1036-3","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3948_CR39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jmoldx.2014.01.005","volume":"16","author":"C Santos","year":"2014","unstructured":"Santos C, Peixoto A, Rocha P, Pinto P, Bizarro S, Pinheiro M, Pinto C, Henrique R, Teixeira MR (2014) Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast\/ovarian cancer families. J Mol Diagn 16(3):324\u2013334. doi: 10.1016\/j.jmoldx.2014.01.005","journal-title":"J Mol Diagn"},{"issue":"7","key":"3948_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/mc.22116","volume":"54","author":"MT Parsons","year":"2015","unstructured":"Parsons MT, Whiley PJ, Beesley J, Drost M, de Wind N, Thompson BA, Marquart L, Hopper JL, Jenkins MA, Australasian Colorectal Cancer Family R, Brown MA, Tucker K, Warwick L, Buchanan DD, Spurdle AB (2015) Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: use of potential alternative start sites and implications for predicting variant pathogenicity. Mol Carcinog 54(7):513\u2013522. doi: 10.1002\/mc.22116","journal-title":"Mol Carcinog"},{"issue":"21","key":"3948_CR41","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, Gauthier-Villars M, Stoppa-Lyonnet D, Consolino E, Brugieres L, Caron O, Benusiglio PR, Bressac-de Paillerets B, Bonadona V, Bonaiti-Pellie C, Tinat J, Baert-Desurmont S, Frebourg T (2015) Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33(21):2345\u20132352. doi: 10.1200\/JCO.2014.59.5728","journal-title":"J Clin Oncol"},{"issue":"11","key":"3948_CR42","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ng1902","volume":"38","author":"S Seal","year":"2006","unstructured":"Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K, North B, McGuffog L, Evans DG, Eccles D, Breast Cancer Susceptibility C, Easton DF, Stratton MR, Rahman N (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38(11):1239\u20131241. doi: 10.1038\/ng1902","journal-title":"Nat Genet"},{"key":"3948_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103529","author":"DF Easton","year":"2016","unstructured":"Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Dennis J, Ahmad J, Thompson ER, Damiola F, Pertesi M, Voegele C, Mebirouk N, Robinot N, Durand G, Forey N, Luben RN, Ahmed S, Aittomaki K, Anton-Culver H, Arndt V, Australian Ovarian Cancer Study G, Baynes C, Beckman MW, Benitez J, Van Den Berg D, Blot WJ, Bogdanova NV, Bojesen SE, Brenner H, Chang-Claude J, Chia KS, Choi JY, Conroy DM, Cox A, Cross SS, Czene K, Darabi H, Devilee P, Eriksson M, Fasching PA, Figueroa J, Flyger H, Fostira F, Garcia-Closas M, Giles GG, Glendon G, Gonzalez-Neira A, Guenel P, Haiman CA, Hall P, Hart SN, Hartman M, Hooning MJ, Hsiung CN, Ito H, Jakubowska A, James PA, John EM, Johnson N, Jones M, Kabisch M, Kang D, kConFab I, Kosma VM, Kristensen V, Lambrechts D, Li N, Lifepool I, Lindblom A, Long J, Lophatananon A, Lubinski J, Mannermaa A, Manoukian S, Margolin S, Matsuo K, Meindl A, Mitchell G, Muir K, Investigators N, Nevelsteen I, van den Ouweland A, Peterlongo P, Phuah SY, Pylkas K, Rowley SM, Sangrajrang S, Schmutzler RK, Shen CY, Shu XO, Southey MC, Surowy H, Swerdlow A, Teo SH, Tollenaar RA, Tomlinson I, Torres D, Truong T, Vachon C, Verhoef S, Wong-Brown M, Zheng W, Zheng Y, Nevanlinna H, Scott RJ, Andrulis IL, Wu AH, Hopper JL, Couch FJ, Winqvist R, Burwinkel B, Sawyer EJ, Schmidt MK, Rudolph A, Dork T, Brauch H, Hamann U, Neuhausen SL, Milne RL, Fletcher O, Pharoah PD, Campbell IG, Dunning AM, Le Calvez-Kelm DE, Goldgar DE, Tavtigian SV, Chenevix-Trench G (2016) No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. J Med Genet. doi: 10.1136\/jmedgenet-2015-103529","journal-title":"J Med Genet"},{"issue":"6","key":"3948_CR44","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/jmedgenet-2015-103398","volume":"53","author":"EL Young","year":"2016","unstructured":"Young EL, Feng BJ, Stark AW, Damiola F, Durand G, Forey N, Francy TC, Gammon A, Kohlmann WK, Kaphingst KA, McKay-Chopin S, Nguyen-Dumont T, Oliver J, Paquette AM, Pertesi M, Robinot N, Rosenthal JS, Vallee M, Voegele C, Hopper JL, Southey MC, Andrulis IL, John EM, Hashibe M, Gertz J, Breast Cancer Family R, Le Calvez-Kelm F, Lesueur F, Goldgar DE, Tavtigian SV (2016) Multigene testing of moderate-risk genes: be mindful of the missense. J Med Genet 53(6):366\u2013376. doi: 10.1136\/jmedgenet-2015-103398","journal-title":"J Med Genet"},{"key":"3948_CR45","doi-asserted-by":"publisher","first-page":"14955","DOI":"10.1038\/srep14955","volume":"5","author":"M Wu","year":"2015","unstructured":"Wu M, Wu J, Chen T, Jiang R (2015) Prioritization Of nonsynonymous single nucleotide variants for exome sequencing studies via integrative learning on multiple genomic data. Sci Rep 5:14955. doi: 10.1038\/srep14955","journal-title":"Sci Rep"},{"key":"3948_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22973","author":"MP Vallee","year":"2016","unstructured":"Vallee MP, Sera TL, Nix DA, Paquette AM, Parsons MT, Bell R, Hoffman A, Hogervorst FB, Goldgar DE, Spurdle AB, Tavtigian SV (2016) Adding in silico assessment of potential splice aberration to the integrated evaluation of brca gene unclassified variants. Hum Mutat. doi: 10.1002\/humu.22973","journal-title":"Hum Mutat"},{"issue":"3","key":"3948_CR47","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10549-009-0438-6","volume":"119","author":"K Sweet","year":"2010","unstructured":"Sweet K, Senter L, Pilarski R, Wei L, Toland AE (2010) Characterization of BRCA1 ring finger variants of uncertain significance. Breast Cancer Res Treat 119(3):737\u2013743. doi: 10.1007\/s10549-009-0438-6","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3948_CR48","doi-asserted-by":"publisher","first-page":"e86836","DOI":"10.1371\/journal.pone.0086836","volume":"9","author":"PJ Whiley","year":"2014","unstructured":"Whiley PJ, Parsons MT, Leary J, Tucker K, Warwick L, Dopita B, Thorne H, Lakhani SR, Goldgar DE, Brown MA, Spurdle AB (2014) Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A\u00a0>\u00a0G(p.His41Arg) is a pathogenic mutation. PLoS ONE 9(1):e86836. doi: 10.1371\/journal.pone.0086836","journal-title":"PLoS ONE"},{"issue":"6","key":"3948_CR49","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/ng.3284","volume":"47","author":"C Cybulski","year":"2015","unstructured":"Cybulski C, Carrot-Zhang J, Kluzniak W, Rivera B, Kashyap A, Wokolorczyk D, Giroux S, Nadaf J, Hamel N, Zhang S, Huzarski T, Gronwald J, Byrski T, Szwiec M, Jakubowska A, Rudnicka H, Lener M, Masojc B, Tonin PN, Rousseau F, Gorski B, Debniak T, Majewski J, Lubinski J, Foulkes WD, Narod SA, Akbari MR (2015) Germline RECQL mutations are associated with breast cancer susceptibility. Nat Genet 47(6):643\u2013646. doi: 10.1038\/ng.3284","journal-title":"Nat Genet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3948-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3948-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3948-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:09:57Z","timestamp":1498324197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3948-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,23]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["3948"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3948-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2016,8,23]]}}}